Published in

Rockefeller University Press, Journal of Experimental Medicine, 10(216), p. 2302-2315, 2019

DOI: 10.1084/jem.20191061

Links

Tools

Export citation

Search in Google Scholar

Risk of Zika microcephaly correlates with features of maternal antibodies

Journal article published in 2019 by Davide F. Robbiani ORCID, Mateus S. do Rosário ORCID, Elsio A. Wunder ORCID, Bruno de Paula Freitas, Isadora C. de Siqueira ORCID, João R. M. de Almeida ORCID, Antonio R. P. de Almeida, Priscilla C. Olsen, Federico Costa, Thiago Y. Oliveira, Nivison Nery ORCID, Adeolu Aromolaran, Gielson A. Sacramento, Jaqueline S. Cruz, Ricardo Khouri and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Zika virus (ZIKV) infection during pregnancy causes congenital abnormalities, including microcephaly. However, rates vary widely, and the contributing risk factors remain unclear. We examined the serum antibody response to ZIKV and other flaviviruses in Brazilian women giving birth during the 2015–2016 outbreak. Infected pregnancies with intermediate or higher ZIKV antibody enhancement titers were at increased risk to give birth to microcephalic infants compared with those with lower titers (P < 0.0001). Similarly, analysis of ZIKV-infected pregnant macaques revealed that fetal brain damage was more frequent in mothers with higher enhancement titers. Thus, features of the maternal antibodies are associated with and may contribute to the genesis of ZIKV-associated microcephaly.